2008 NF Conference
2008 NF Conference
批准号:
7539829
负责人:
Gina Agiostratidou
金额:
$4.2万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-06-01 至 2009-05-31
关键词:
AddressAwardAwarenessBiochemicalCaringChildClinicClinicalClinical DataClinical ResearchClinical TrialsClinical Trials NetworkCollaborationsCommunitiesConsensusDataDiamondElementsFloridaFosteringFoundationsFundingGenesGoalsGoldGrowthIncentivesIndividualIndustryInternationalLinkMalignant NeoplasmsMedicalModelingMolecularNewsletterNumbersOralPharmacologic SubstancePhasePlatinumPlayPublic HealthRangeRecording of previous eventsRequest for ApplicationsResearchResearch PersonnelResortRoleScientistSilverSystemTimeTranslational ResearchTravelWorkabstractingbench to bedsidedayinnovationnervous system disordernovel strategiespostersprogramssymposiumtumor
中文摘要
描述(由申请人提供):本申请申请为儿童肿瘤基金会国际NF会议2008年年会提供资金支持。会议将于2008年6月6日至10日在佛罗里达州博尼塔斯普林斯椰子角凯悦酒店举行。自1985年成立以来,这个年度会议已经取得了丰硕的成果,它作为NF社区研究人员和临床医生的首要年度聚会发挥着关键作用。该会议是为来自世界各地的研究人员提供研究信息交流和讨论的论坛,传统上促进了合作、共识的建立和转化研究的进展,最终实现了临床试验。今年的一项创新是扩大了NF会议,增加了两天的临床数据。要求在NF会议中加入更多的临床元素,标志着NF研究正从实验室走向临床。2005年美国陆军资助的二期NF临床试验联盟的出现,在过去两年中刺激了NF临床医生和基础研究人员之间更多的互动,这在NF会议上得到了证明。2007年CTF转化项目的空前增长,包括NF临床网络和临床试验奖,刺激了临床医生和科学家之间的进一步互动。从基础到临床,这是NF研究在许多方面取得巨大进展的时代,这反映在2008年会议的主题-“基因到治疗到并发症”中。12个单独的会议将带领联盟从临床护理数据到NF的分子机制和转化模型到临床治疗。演讲者将包括初级和高级研究人员。本次会议的目的是将临床研究、生物化学、细胞和有机体系统的最新发现并列起来。每次会议还将包括由NF研究之外的主要研究者发表主题演讲,以展开广泛的讨论。有竞争力的旅行奖将邀请年轻的研究人员进行口头报告,两个海报会议将允许研究人员向NF社区展示他们的工作。最后,2008年NF会议增加了两个小组讨论,这将激发与会者对NF医学界有争议问题的讨论。我们采取了两种新方法,以提高这次会议和NF研究状况的可见度。首先,为了提高行业对NF的认识,我们将向大量的制药公司寻求本次会议的财政赞助。奖励赞助将提供钻石,白金,金和银级别。其次,联合主席和基金会将共同努力,在NF通讯以及NF研究电子新闻简报中向10,000多人传播NF会议的完整摘要。这些行动将促进整个研究界了解NF研究的现状、与其他癌症和神经系统疾病的联系以及需要解决的主要障碍。公共卫生相关性:儿童肿瘤基金会国际NF会议自1985年成立以来已经取得了丰硕的成果,它作为NF社区研究人员和临床医生的首要年度聚会发挥着关键作用。该会议是为来自世界各地的研究人员提供研究信息交流和讨论的论坛,传统上促进了合作、共识的建立和转化研究的进展,最终实现了临床试验。
英文摘要
DESCRIPTION (provided by applicant): This application requests funding support for the 2008 annual meeting of the Children's Tumor Foundation International NF Conference. The Meeting will be held June 6th-10th, 2008, at the Hyatt Regency Coconut Point Resort, Bonita Springs, Florida. This annual meeting has had a fruitful history since its inception in 1985, and it plays a lynchpin role as the premier annual gathering of researchers and clinicians in the NF community. The meeting is a forum for research information exchange and discussion for researchers from around the world, and has traditionally fostered collaboration, consensus building, and advances in translational research culminating in clinical trials. An innovation this year is the expansion of the NF conference with two additional days of clinical data. The demand to include a larger clinical element to the NF Conference is a marker of the progression NF research is making from bench to bedside. The advent of the US Army-funded Phase II NF Clinical Trials Consortium in 2005 has stimulated more interaction between NF clinicians and basic researchers over the past two years and this has been evidenced at the NF Conference. The unprecedented growth of CTF translational programs in 2007, including an NF Clinic Network and Clinical Trial Awards, stimulates further interactions between clinicians and scientists. This is a time of tremendous advances in NF research on many fronts, from basic through clinical, and this is reflected in the theme of the 2008 meeting - "Genes to Therapies to Complications". Twelve individual sessions will take the Consortium from clinical care data to molecular mechanisms of NF and translational models to clinical therapies. Speakers will include both junior and senior researchers. The goal of this meeting is to juxtapose current findings in clinical studies, biochemical, cellular and organismal systems. Each session will also include a keynote address by a leading investigator from outside of NF research to open up broad ranging discussions. Competitive travel awards will bring young investigators for oral presentations, and two poster sessions will allow investigators to present their work to the NF community. Finally, another addition in the 2008 NF conference is the two panel discussions, which will stimulate discussions among the attendees for controversial issues in NF medical community. We have taken two new approaches in order to increase the visibility of this meeting and of the state of NF research. First, to increase industry awareness of NF, we will seek fiscal sponsorship for this meeting from a large number of pharmaceutical companies. Incentive sponsorships will be offered at diamond, platinum, gold and silver levels. Secondly, the cochairs and the Foundation will work together to disseminate a full summary of the NF conference in the NF Newsletter as well in the NF Research E-NewsBlast to over 10,000 individuals. These actions will promote to the research community at large the status of NF research, the link with other cancers and neurological disorders and the key barriers to be addressed. PUBLIC HEALTH RELEVANCE: The Children's Tumor Foundation International NF Conference has had a fruitful history since its inception in 1985, and it plays a lynchpin role as the premier annual gathering of researchers and clinicians in the NF community. The meeting is a forum for research information exchange and discussion for researchers from around the world, and has traditionally fostered collaboration, consensus building, and advances in translational research culminating in clinical trials.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金